We are monitoring the impact of COVID-19 & Recession alarm on Latin America Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Share on

Latin America Vaccine Adjuvant Market Research Report – Segmented By Type, Route Of Administration, Mechanism Of Action And Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 627
Pages: 145

Latin America Vaccine Adjuvant Market Size (2022 to 2027)

The Vaccine Adjuvant Market in Latin America is expected to grow at a CAGR of 11.35% from 2022 to 2027. The market size is predicted to be worth USD 154.6 million by 2027 from USD 90.33 million in 2022. 

Adjuvants are used for decades to develop the immune response towards vaccine antigens. They perk up the body's immune response and regularly allow for slighter amounts of a deactivated virus or bacteria to be used in a vaccine. Though, more than one adjuvant may be present in the final vaccine product.

The necessity for these products will increase as adjuvants will be required to improve and spread immune responses while decreasing the quantity of antigen essential for each dose. The limited immunogenicity of different and new vaccine antigens has amplified the significance of adjuvant research in vaccine improvement. There is a necessity for the development of harmless and non-toxic adjuvants. Vaccines comprising novel adjuvant formulations are progressively developing and started reaching licensing stages, providing new tools to fill previously unmet clinical needs.

Conversely, many adjuvants miss the mark during product development due to unacceptable levels of tolerability or safety concerns; stability, lack of effectiveness, and manufacturability are some of the factors impeding the market's growth rate.

This research report on the Latin American vaccine adjuvant market has been segmented and sub-segmented into the following categories:

By Type: 

  • Aluminum Salts
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Bacteria Derived Adjuvants
  • Liposome Adjuvants
  • Carbohydrate Adjuvants

By Route Of Administration: 

  • Oral
  • Intradermal
  • Subcutaneous
  • Intranasal
  • Intramuscular

By Mechanism Of Action: 

  • Immuno Stimulants
  • Carriers
  • Vehicle Adjuvants

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

In 2020, the Brazilian vaccine adjuvant market accounted for the highest share in the Latin American market due to the developed healthcare sector and rising government funding to introduce the new innovative product. In addition, a growing pandemic of influenza in Brazil demands further production of an O/W emulsion vaccine adjuvant is driving the market's growth. Recently, using Xantham Gum emulsifying agent in vaccine adjuvant to detect the in vitro clinical trials of immune response will boost the market's growth.

The Mexican vaccine adjuvant market is expected to grow at the fastest CAGR during the forecast period in the Latin American market. Due to the less effective trivalent influenza vaccine, World Health Organization (WHO) has initiated clinical trials on vaccine adjuvant, which helps boost immune response in children, adults, and aged people, propelling the growth of the Mexico vaccine adjuvant market. Also, the demands for long-lasting immunity against melanoma, malaria, and tuberculosis are attributed to the increase in the market.

The high prevalence of hepatitis B and significant demand for DNA vaccine adjuvant to protect against the bovine herpes virus in cattle is driven by the growth of the vaccine adjuvants market in Argentina. In addition, a newly launched pediatric vaccine the Argentina government has approved adjuvant is propelling the market's growth. Also, the availability of a cost-effective MF-59 TIV adjuvanted vaccine will help to enhance the market growth.

KEY MARKET PLAYERS:

Companies playing a prominent role in the Latin American vaccine adjuvant market profiled in this report are MPV Technologies, Avanti Polar Lipids, Novavax Inc. Brenntag Biosector, SEPPIC, Agenus, Inc., Invivogen, SPI Pharma, Inc., CSL Limited, and OZ Biosciences.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Argentina    

                                6.5 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Vaccine Adjuvant Market, By Region, From 2022 - 2027 (USD Million)
  2. Latin America Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  3. Latin America Aluminium Salts Market, By Region, From 2022 - 2027 (USD Million)
  4. Latin America Tensoactive Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  5. Latin America Adjuvant Emulsions Market, By Region, From 2022 - 2027 (USD Million)
  6. Latin America Bacteria derived Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  7. Latin America Liposome Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  8. Latin America Carbohydrate Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  9. Latin America Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  10. Latin America Oral Market, By Region, From 2022 - 2027 (USD Million)
  11. Latin America Intradermal Market, By Region, From 2022 - 2027 (USD Million)
  12. Latin America Subcutaneous Market, By Region, From 2022 - 2027 (USD Million)
  13. Latin America Intranasal Market, By Region, From 2022 - 2027 (USD Million)
  14. Latin America Intramuscular Market, By Region, From 2022 - 2027 (USD Million)
  15. Latin America Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  16. Latin America Immuno Stimulants Market, By Region, From 2022 - 2027 (USD Million)
  17. Latin America Carriers Market, By Region, From 2022 - 2027 (USD Million)
  18. Latin America Vehicle Adjuvants Market, By Region, From 2022 - 2027 (USD Million)
  19. Brazil Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  20. Brazil Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  21. Brazil Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  22. Argentina Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  23. Argentina Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  24. Argentina Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)
  25. Mexico Vaccine Adjuvant Market, By Type, From 2022 - 2027 (USD Million)
  26. Mexico Vaccine Adjuvant Market, By Route of Administration , From 2022 - 2027 (USD Million)
  27. Mexico Vaccine Adjuvant Market, By Mechanism of Action, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample